Risk factors for hepatic decompensation in cirrhotic patients with HIV/HCV co-infection treated with pegylated interferon-alpha or interferon-alpha and rivbavirin, or placebo

ANTIVIRAL THERAPY(2003)

引用 0|浏览6
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要